Understanding how glyoxalase-1 is regulated in the body
Official title: Exploring regulatory mechanisms of glyoxalase-1
Funded at University of Michigan at Ann Arbor · NIH-10828440 · Data updated 2026-11-12
This study is looking at how a protein called glyoxalase-1 helps protect our cells from a harmful substance that can cause damage, especially as we age or if we're dealing with obesity, to find ways to improve health and reduce risks of age-related diseases.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | April 15, 2023 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $195,000 |
| NIH project number | 5R21AG081916-02 |
| Project ID | NIH-10828440 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults over 21 years old, particularly those experiencing obesity or age-related metabolic issues.
✕Less likely to help
Patients who are under 21 years old or do not have metabolic conditions related to aging may not benefit from this research.
What this research studies
This research investigates the role of glyoxalase-1 (GLO1) in detoxifying methylglyoxal, a harmful compound that can lead to cellular damage and age-related diseases. By studying how GLO1 is regulated in skeletal muscle tissue, the research aims to uncover the mechanisms that affect its stability and activity, particularly in the context of obesity and aging. The approach includes developing advanced models to simulate and analyze the effects of reduced GLO1 levels on cellular function and metabolism. This could provide insights into how to mitigate the negative impacts of dicarbonyl stress on health.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating age-related diseases and metabolic disorders.
How similar studies have gone: Previous research has shown that understanding the regulation of metabolic enzymes like GLO1 can lead to significant advancements in treating metabolic disorders, indicating that this approach has potential for success.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Haus, Jacob M — University of Michigan at Ann Arbor
- Study coordinator: Haus, Jacob M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.